WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly

Longer subscriptions offer lower monthly pricing, with people expected to save up to $1,200 a year on the injection and as much as $600 a year on the pill.

Raccontata daforbes.comcnbc.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
cnbc.comStai leggendo3 mesi fa

Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli…

Longer subscriptions offer lower monthly pricing, with people expected to save up to $1,200 a year on the injection and as much as $600 a year on the pill.

originale
forbes.com3 mesi fa

Wegovy Subscription Launched—Here’s How Much It Could Save Users A Year

Novo Nordisk says people will save up to $1,200 per year on the Wegovy injection and $600 per year on the pill under the new program.

Leggi questa versione → originale

Timeline cronologica

  1. martedì 31 marzo 2026·forbes.com

    Wegovy Subscription Launched—Here’s How Much It Could Save Users A Year

    Novo Nordisk says people will save up to $1,200 per year on the Wegovy injection and $600 per year on the pill under the new program.

  2. martedì 31 marzo 2026·cnbc.com

    Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly

    Longer subscriptions offer lower monthly pricing, with people expected to save up to $1,200 a year on the injection and as much as $600 a year on the pill.

  3. mercoledì 1 aprile 2026·cnbc.com

    Novo Nordisk shares rise after Wegovy recommended by Britain's drug price regulator

    The new recommendation will significantly expand access to Wegovy on the England's NHS.

  4. giovedì 2 aprile 2026·cnbc.com

    Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison

    Novo and Eli Lilly are both trying to shape the narrative of their rival pills, considered to be the start of the next phase of the weight-loss drug era.